Comparative Analysis of Immaturity CD Markers in Acute Lymphoblastic Leukemia Reveals Significance

Researchers at the University of Basrah have conducted a comparative analysis of immaturity CD markers in acute lymphoblastic leukemia (ALL) among children and adults, highlighting significant variations in marker expression between the two groups. The study, published in Acta Medica, aimed to assess the expression levels of CD34, HLA-DR, TdT, and CD38 in 130 ALL patients, including pediatric and adult B-ALL and T-ALL subtypes. The findings have implications for diagnostic and therapeutic strategies in ALL treatment.

Key Takeaways:

  • The study included 130 ALL patients, with 51 pediatric B-ALL, 16 pediatric T-ALL, 44 adult B-ALL, and 19 adult T-ALL patients.
  • CD marker expressions were analyzed, including CD34, HLA-DR, TdT, and CD38, using Shapiro-Wilk test and Mann-Whitney U tests.
  • Descriptive statistics revealed variability in CD marker expression levels among the different subtypes of ALL.
  • Independent samples t-tests and Mann-Whitney U tests revealed statistically significant differences (p < 0.05) in marker expression levels between groups.
  • The research concluded that the patterns of CD marker expression may reveal biological differences influencing disease development, treatment results, and patient survival outcomes.
  • The study has implications for developing diagnostic and therapeutic strategies in ALL treatment, particularly in identifying biomarkers for disease subtypes.

Statistics:

  • 130 ALL patients were included in the study, comprising 51 pediatric B-ALL, 16 pediatric T-ALL, 44 adult B-ALL, and 19 adult T-ALL patients.
  • CD marker expressions were analyzed in 130 patients.
  • Descriptive statistics showed variability in CD marker expression levels among the different subtypes of ALL.
  • Independent samples t-tests revealed statistically significant differences (p < 0.05) in marker expression levels between groups.
  • Mann-Whitney U tests revealed statistically significant differences (p < 0.05) in marker expression levels between pediatric and adult T-ALL groups.

Sources:

  • (Wiley-Blackwell - www.wiley.com/; Acta Medica - onlinelibrary.wiley.com/journal/10.1111/(ISSN)1563-2571)
  • NewsRx. Reports from University of Basrah Highlight Recent Findings in Acute Lymphoblastic Leukemia (Comparative Analysis of Immaturity CD Markers Expression between Pediatric and Adult Acute Lymphoblastic Leukemia: Insights and Implications for Diagnostic and Therapeutic Strategies). Hematology Week. October 20, 2025; p 454.